 |
| Leading cost containers in 53 industries, 2000-2003. |
|
|
CFO Staff,
CFO Magazine
|
|
| Biotech |
| Company |
2003 COGS |
2003 SG&A |
2003 CMI1 |
2001-2003 Average CMI |
2000-2003
CMI Change2 |
2000-2003
Revenue Growth3 |
| AMGEN |
12 |
43 |
55 |
53 |
354 |
32 |
| GENZYME |
23 |
50 |
73 |
69 |
1157 |
32 |
| GENENTECH |
13 |
57 |
70 |
71 |
-578 |
26 |
| ALLERGAN |
16 |
56 |
72 |
73 |
-517 |
3 |
| CHIRON |
30 |
48 |
78 |
77 |
28 |
23 |
| Industry Median |
16 |
50 |
72 |
71 |
28 |
26 |
All values are % of operating revenue except for 2000-2003 CMI change, which is expressed in basis points.
1CMI = (COGS + SG&A) / operating revenue.
For banking, CMI = (noninterest expense) / (net interest expense income + noninterest income).
2 Nominal change in CMI 2000-2003, expressed in basis points.
3 Compound annual growth in revenue.
Analysis performed by Archstone Consulting, based on data from Compustat and other sources.
Return to the article "Controlling the Flow."
|
Video
